Comparison of Effects of Rodiosensitization Between CMNa and Paclitaxel(TAX) in Treating Intermediate or Advanced Nonsmall Cell Lung Cancer
Objective To compare the effects of rodiosensitization between CMNa and paclitaxel(TAX) in treating intermediate or advanced non-small cell lung cancer(NSCLC). Methods total of 96 patients with intermediate or advanced stage NSCLC were divided into CMNa group.TAX group and control group by different therapy regimens. The CMNa group was treated with CMNa 1.0 g three a week plus radiotherapy. TAX group was treated with TAX 60mg once a week plus radiotherapy. The control group was treated radiotherapy only. Results There were significant differences in the effective rate and radiosensitization between the CMNa group or TAX group and the control group (P<0.05), but Without significant difference between the CMNa group and TAX group(P>0. 05). There was significant difference in the side effects of gastrointestinal tract and hematological system between the CMNa group and the TAX group (P<0.01). Conclusion There is no significant differences in the effective rate and radiosensitization between the CMN and TAX for intermediate or advanced NSCLC. , and CMNa is better than TAX in the () adverse reactions of gastrointestinal tract and hematological system.
NETL
NSTL
万方数据
维普
